Search results
Gilead Sciences: Native Health Navigator Program Connects
3BL CSRwire· 16 hours agoOlivia Sloan was pursuing a career in health policy and research when her father was diagnosed with...
Taking a look at what insiders are doing to gauge the Gilead Sciences, Inc.
Knox Daily· 6 days agoThe buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Gilead Sciences, Inc. shares ...
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
Zacks· 6 days agoFree Report) has recently been on Zacks.com's list of the most searched stocks. During this period, the Zacks Medical - Biomedical and Genetics industry, which Gilead falls in, has lost 0.4% ...
Decoding Gilead Sciences's Options Activity: What's the Big Picture? - Gilead Sciences (NASDAQ:GILD)
Benzinga· 6 days agoLoading... Loading... Financial giants have made a conspicuous bullish move on Gilead Sciences. Our analysis of options history for Gilead</ ...
Gilead’s FOCUS Program Helps Zero In on Early HIV
3BL CSRwire· 6 days agoA 22-year-old college student who didn’t feel well was treated at an urgent care facility in Baton Rouge, Louisiana and expected to recover soon. When the test came back positive, the student ...
US FDA approves expanded use of Bristol Myers' cancer cell therapy
Reuters· 12 hours ago, opens new tab cancer cell therapy Breyanzi for the treatment of adults with a type of blood cancer...
Kite and Arcellx to start Phase 3 trial for myeloma therapy By Investing.com
Investing.com· 6 days agoREDWOOD CITY, Calif. & SANTA MONICA, Calif. - Kite, a Gilead Company (NASDAQ: GILD), and Arcellx,...
One stock is dragging down the S&P 500's earnings growth
AOL· 3 days agoCompanies in the S&P 500 (^GSPC) have reported what's broadly been considered a solid Q1 earnings season for the index, with one key exception: drugmaker Bristol Myers Squibb (BMY). Last month ...
California Supreme Court to Review Newly Created Duty to Market a “Safer” Product Even in the...
JD Supra· 6 days agoOn May 1, the California Supreme Court granted Gilead Science Inc.’s request to review a California appellate court’s holding that the pharmaceutical manufacturer ...
Biotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing Medicine
InvestorPlace via Yahoo Finance· 7 days agoBiotech breakthrough stocks, along with the sector overall, faced significant challenges over the...